Lumigan
Lumigan is a prescription eye drop containing bimatoprost, a synthetic prostaglandin analog. It is used to lower high pressure inside the eye by increasing the natural outflow of ocular fluid.
Dosage by Body Weight
The recommended dosage is one drop in the affected eye(s) once daily in the evening. Do not exceed once-daily dosing, as more frequent administration may decrease the intraocular pressure-lowering effect.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under the age of 16 have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under the age of 16 have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under the age of 16 have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under the age of 16 have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under the age of 16 have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under the age of 16 have not been established. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under the age of 16 have not been established. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under the age of 16 have not been established. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under the age of 16 have not been established. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under the age of 16 have not been established. |
Formulation
Purpose
Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Generic Name
BimatoprostScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.